In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alnara Pharmaceuticals Inc.

Division of Eli Lilly & Co.
www.alnara.com

Latest From Alnara Pharmaceuticals Inc.

Stockwatch: 2017, Year Of The Dog

News in the life sciences sector over the holiday period was peppered with clinical and regulatory failures at Acadia, Anthera, Opko and Cempra, and a drug pricing controversy from Biogen. Following underperformance in 2016 and with that sort of run-up, 2017 already looks likely to be another lost one.

Commercial Clinical Trials

Westphal's Flex Pharma raises $40m for muscle cramp supplement

Serial biotechnology entrepreneur Christoph Westphal, who co-founded companies such as Alnylam Pharmaceuticals and Verastem, now is backing a private firm that's raised $40m to develop a nutritional supplement to relieve muscle cramps.

Cancer Orthopedics

Anthera acquires troubled Sollpura from Lilly

Anthera Pharmaceuticals acquired Sollpura (liprotamase), a non-porcine pancreatic enzyme replacement therapy (PERT) with a long and troubled history in exocrine pancreatic insufficiency (EPI), from Eli Lilly for an undisclosed price.

Gastrointestinal Dermatology

As Some VCs Refill, Others Are Running Out Of Gas

Life science VCs are posting strong across-the-board returns, allowing some firms to raise new funds larger than their prior vehicles. Still, the contraction that began nearly five years ago continues to thwart other firms’ efforts to press on through hard times.

BioPharmaceutical North America
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Eli Lilly & Co.
  • Senior Management
  • Alexey Margolin, PhD, Pres. & CEO
    Lee R Brettman, MD, CMO
    Robert Gallotto, CBO
    Thomas Rowland, VP, Commercial Dev.
  • Contact Info
  • Alnara Pharmaceuticals Inc.
    Phone: (617) 349-3690
    840 Memorial Dr.
    Cambridge, MA 02139
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register